Ken Griffin Eargo, Inc. Transaction History

Citadel Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.49 - $0.73 $22,968 - $34,218	46,875 Added 162.3%	75,756 $43,000
Q3 2022 Nov 14, 2022	SELL	$0.7 - $3.0 $319,624 - $1.37 Million	-456,607 Reduced 94.05%	28,881 $30,000
Q2 2022 Aug 15, 2022	BUY	$0.75 - $5.6 $113,394 - $846,675	151,192 Added 45.23%	485,488 $365,000
Q1 2022 May 16, 2022	SELL	$3.3 - $7.28 $147,262 - $324,870	-44,625 Reduced 11.78%	334,296 $1.77 Million
Q4 2021 Feb 14, 2022	BUY	$4.6 - $10.21 $1.17 Million - $2.6 Million	254,503 Added 204.55%	378,921 $1.93 Million
Q3 2021 Nov 15, 2021	BUY	$6.59 - $38.71 $304,023 - $1.79 Million	46,134 Added 58.93%	124,418 $838,000
Q2 2021 Aug 16, 2021	BUY	$32.1 - $57.78 $830,427 - $1.49 Million	25,870 Added 49.36%	78,284 $3.12 Million
Q4 2020 Feb 16, 2021	BUY	$33.49 - $57.94 $1.76 Million - $3.04 Million	52,414 New	52,414 $2.35 Million

33.4K

Ticker EAR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 39,411,000
Market Cap $2.78B
Description
Eargo, Inc., a medical device company, engages in enhancing the quality of life of people with hearing loss in the United States. The company markets and sells hearing aids. It sells its products direct-to-consumer and through omni-channel. The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.